vs
OHIO VALLEY BANC CORP（OVBC）与ARS Pharmaceuticals, Inc.（SPRY）财务数据对比。点击上方公司名可切换其他公司
ARS Pharmaceuticals, Inc.的季度营收约是OHIO VALLEY BANC CORP的1.7倍（$28.1M vs $16.2M），OHIO VALLEY BANC CORP净利率更高（24.4% vs -147.1%，领先171.5%），OHIO VALLEY BANC CORP同比增速更快（-4.6% vs -67.6%）
俄亥俄谷银行公司旗下的亚利桑那 Valley 国民银行总部位于亚利桑那州凤凰城，成立于1900年，1992年被第一银行收购。该银行是20世纪亚利桑那州顶尖的金融机构之一，在被收购时是该州最后一家大型独立银行。
ARS Pharmaceuticals是一家处于后期研发阶段的生物制药企业，专注于开发和商业化严重过敏反应创新疗法，核心产品为无需注射的肾上腺素鼻腔递送制剂，主要面向北美市场，服务存在致命过敏风险的成人及儿童患者群体。
OVBC vs SPRY — 直观对比
营收规模更大
SPRY
是对方的1.7倍
$16.2M
营收增速更快
OVBC
高出62.9%
-67.6%
净利率更高
OVBC
高出171.5%
-147.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.2M | $28.1M |
| 净利润 | $4.0M | $-41.3M |
| 毛利率 | — | — |
| 营业利润率 | 30.7% | -147.6% |
| 净利率 | 24.4% | -147.1% |
| 营收同比 | -4.6% | -67.6% |
| 净利润同比 | 57.3% | -182.8% |
| 每股收益（稀释后） | — | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OVBCSPRY
| Q4 25 | $16.2M | $28.1M | ||
| Q3 25 | $16.3M | $32.5M | ||
| Q2 25 | $17.4M | $15.7M | ||
| Q1 25 | $16.8M | $8.0M | ||
| Q4 24 | $17.0M | $86.6M | ||
| Q3 24 | $15.4M | $2.1M | ||
| Q2 24 | $14.7M | $500.0K | ||
| Q1 24 | $14.9M | $0 |
净利润OVBCSPRY
| Q4 25 | $4.0M | $-41.3M | ||
| Q3 25 | $3.0M | $-51.2M | ||
| Q2 25 | $4.2M | $-44.9M | ||
| Q1 25 | $4.4M | $-33.9M | ||
| Q4 24 | $2.5M | $49.9M | ||
| Q3 24 | $2.7M | $-19.1M | ||
| Q2 24 | $3.0M | $-12.5M | ||
| Q1 24 | $2.8M | $-10.3M |
营业利润率OVBCSPRY
| Q4 25 | 30.7% | -147.6% | ||
| Q3 25 | 22.9% | -163.7% | ||
| Q2 25 | 29.8% | -302.9% | ||
| Q1 25 | 33.1% | -466.3% | ||
| Q4 24 | 18.1% | 54.5% | ||
| Q3 24 | 21.3% | -1051.6% | ||
| Q2 24 | 24.7% | -3068.0% | ||
| Q1 24 | 22.8% | — |
净利率OVBCSPRY
| Q4 25 | 24.4% | -147.1% | ||
| Q3 25 | 18.5% | -157.4% | ||
| Q2 25 | 24.2% | -285.6% | ||
| Q1 25 | 26.2% | -425.7% | ||
| Q4 24 | 14.8% | 57.7% | ||
| Q3 24 | 17.6% | -925.0% | ||
| Q2 24 | 20.3% | -2503.2% | ||
| Q1 24 | 18.8% | — |
每股收益（稀释后）OVBCSPRY
| Q4 25 | — | $-0.41 | ||
| Q3 25 | — | $-0.52 | ||
| Q2 25 | — | $-0.46 | ||
| Q1 25 | — | $-0.35 | ||
| Q4 24 | — | $0.52 | ||
| Q3 24 | — | $-0.20 | ||
| Q2 24 | — | $-0.13 | ||
| Q1 24 | — | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $45.9M | $245.0M |
| 总债务越低越好 | — | $96.4M |
| 股东权益账面价值 | $170.3M | $114.3M |
| 总资产 | $1.6B | $327.7M |
| 负债/权益比越低杠杆越低 | — | 0.84× |
8季度趋势，按日历期对齐
现金及短期投资OVBCSPRY
| Q4 25 | $45.9M | $245.0M | ||
| Q3 25 | $89.3M | $288.2M | ||
| Q2 25 | $54.6M | $240.1M | ||
| Q1 25 | $120.6M | $275.7M | ||
| Q4 24 | $83.1M | $314.0M | ||
| Q3 24 | $82.2M | $204.6M | ||
| Q2 24 | $107.7M | $218.7M | ||
| Q1 24 | $129.1M | $223.6M |
总债务OVBCSPRY
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益OVBCSPRY
| Q4 25 | $170.3M | $114.3M | ||
| Q3 25 | $164.4M | $147.7M | ||
| Q2 25 | $160.8M | $192.3M | ||
| Q1 25 | $155.7M | $229.0M | ||
| Q4 24 | $150.3M | $256.8M | ||
| Q3 24 | $152.2M | $201.0M | ||
| Q2 24 | $145.8M | $215.2M | ||
| Q1 24 | $145.8M | $223.9M |
总资产OVBCSPRY
| Q4 25 | $1.6B | $327.7M | ||
| Q3 25 | $1.6B | $372.8M | ||
| Q2 25 | $1.5B | $313.5M | ||
| Q1 25 | $1.5B | $327.3M | ||
| Q4 24 | $1.5B | $351.2M | ||
| Q3 24 | $1.5B | $217.6M | ||
| Q2 24 | $1.4B | $222.0M | ||
| Q1 24 | $1.4B | $227.6M |
负债/权益比OVBCSPRY
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.1M | $-43.5M |
| 自由现金流经营现金流 - 资本支出 | $17.0M | — |
| 自由现金流率自由现金流/营收 | 105.2% | — |
| 资本支出强度资本支出/营收 | 6.4% | 0.0% |
| 现金转化率经营现金流/净利润 | 4.57× | — |
| 过去12个月自由现金流最近4个季度 | $26.5M | — |
8季度趋势，按日历期对齐
经营现金流OVBCSPRY
| Q4 25 | $18.1M | $-43.5M | ||
| Q3 25 | $5.3M | $-47.0M | ||
| Q2 25 | $4.5M | $-39.6M | ||
| Q1 25 | $496.0K | $-40.7M | ||
| Q4 24 | $13.1M | $42.0M | ||
| Q3 24 | $5.6M | $-14.5M | ||
| Q2 24 | $4.2M | $-7.3M | ||
| Q1 24 | $928.0K | $-6.7M |
自由现金流OVBCSPRY
| Q4 25 | $17.0M | — | ||
| Q3 25 | $5.0M | $-47.2M | ||
| Q2 25 | $4.4M | $-39.6M | ||
| Q1 25 | $138.0K | $-40.8M | ||
| Q4 24 | $11.7M | $41.7M | ||
| Q3 24 | $5.4M | $-14.6M | ||
| Q2 24 | $3.9M | $-7.3M | ||
| Q1 24 | $234.0K | $-6.8M |
自由现金流率OVBCSPRY
| Q4 25 | 105.2% | — | ||
| Q3 25 | 30.4% | -145.4% | ||
| Q2 25 | 25.1% | -252.2% | ||
| Q1 25 | 0.8% | -512.1% | ||
| Q4 24 | 68.7% | 48.2% | ||
| Q3 24 | 35.1% | -706.3% | ||
| Q2 24 | 26.3% | -1463.4% | ||
| Q1 24 | 1.6% | — |
资本支出强度OVBCSPRY
| Q4 25 | 6.4% | 0.0% | ||
| Q3 25 | 2.1% | 0.6% | ||
| Q2 25 | 0.6% | 0.3% | ||
| Q1 25 | 2.1% | 1.1% | ||
| Q4 24 | 8.4% | 0.3% | ||
| Q3 24 | 1.2% | 6.8% | ||
| Q2 24 | 2.2% | 7.6% | ||
| Q1 24 | 4.7% | — |
现金转化率OVBCSPRY
| Q4 25 | 4.57× | — | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.06× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | 5.21× | 0.84× | ||
| Q3 24 | 2.06× | — | ||
| Q2 24 | 1.41× | — | ||
| Q1 24 | 0.33× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OVBC
暂无分部数据
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
